News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,685 Results
Type
Article (2449)
Company Profile (40)
Press Release (36196)
Section
Business (14363)
Career Advice (77)
Deals (2120)
Drug Delivery (8)
Drug Development (4122)
Employer Resources (10)
FDA (449)
Job Trends (782)
News (20449)
Policy (1086)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (150)
Allergies (4)
Alliances (3538)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (14)
Approvals (452)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Bankruptcy (11)
Best Places to Work (495)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (17)
Cancer (127)
Cardiovascular disease (4)
Career advice (64)
Career pathing (1)
CAR-T (14)
Cell therapy (41)
Cervical cancer (2)
Clinical research (3184)
Collaboration (87)
Compensation (43)
COVID-19 (184)
CRISPR (7)
C-suite (25)
Cystic fibrosis (2)
Data (97)
Denatured (3)
Depression (3)
Diabetes (9)
Diagnostics (472)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4290)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6080)
Executive appointments (85)
FDA (490)
Featured Employer (3)
Funding (74)
Gene editing (14)
Gene therapy (16)
GLP-1 (60)
Government (155)
Healthcare (757)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (14)
Indications (2)
Infectious disease (189)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (1004)
IRA (7)
Job creations (291)
Job search strategy (62)
Kidney cancer (4)
Labor market (3)
Layoffs (36)
Leadership (1)
Legal (220)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (18)
MASH (3)
Medical device (327)
Medtech (327)
Mergers & acquisitions (1176)
Metabolic disorders (31)
Multiple sclerosis (6)
Neurodegenerative disease (7)
Neuropsychiatric disorders (3)
Neuroscience (88)
NextGen: Class of 2025 (373)
Non-profit (173)
Northern California (325)
Now hiring (4)
Obesity (15)
Opinion (15)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (19)
Patient recruitment (2)
Peanut (1)
People (5694)
Pharmaceutical (5)
Phase I (1375)
Phase II (1598)
Phase III (851)
Pipeline (62)
Podcasts (4)
Policy (10)
Postmarket research (30)
Preclinical (592)
Press Release (2)
Prostate cancer (4)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (21)
Real estate (434)
Recruiting (5)
Regulatory (821)
Reports (6)
Research institute (145)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (24)
Series B (5)
Service/supplier (2)
Sickle cell disease (2)
Southern California (330)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (491)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1607)
Vaccines (29)
Venture capitalists (7)
Webinars (2)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Last 7 days (44)
Last 30 days (190)
Last 365 days (2555)
2025 (587)
2024 (2633)
2023 (2873)
2022 (3802)
2021 (4099)
2020 (3573)
2019 (2144)
2018 (1625)
2017 (1821)
2016 (1641)
2015 (1845)
2014 (1385)
2013 (1201)
2012 (1409)
2011 (1336)
2010 (1192)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1869)
Australia (298)
California (758)
Canada (128)
China (36)
Colorado (19)
Connecticut (10)
Delaware (3)
Europe (3828)
Florida (43)
Georgia (5)
Idaho (4)
Illinois (18)
India (1)
Indiana (30)
Japan (7)
Kansas (12)
Maryland (24)
Massachusetts (279)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (2)
New Hampshire (2)
New Jersey (67)
New York (44)
North Carolina (89)
Northern California (325)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (43)
Rhode Island (2)
South America (42)
South Carolina (1)
Southern California (330)
Tennessee (2)
Texas (62)
Utah (2)
Virginia (5)
Washington D.C. (1)
Washington State (43)
Wisconsin (6)
38,685 Results for "meridian bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Meridian Bioscience Congratulates Catherine Lufkin For Receiving Pure Earth’s 2025 “Force Of Nature” Award
March 6, 2025
·
4 min read
BioMidwest
Meridian Bioscience Unveils Industry-First Lyophilized Library Prep Kit for Next-Generation Sequencing, Eliminating the Need for Cold-Chain Shipping and Storage
The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, proudly introduces the market’s first innovative lyophilized Next-Generation Sequencing library preparation kit.
June 26, 2024
·
4 min read
BioMidwest
Meridian Bioscience Drives Democratization of Next-Generation Sequencing (NGS) with Reagents Enabling Ambient Temperature Shipping and Storage of Sequencing Kits
The Life Science division of Meridian Bioscience, Inc. has announced the launch of a comprehensive menu of glycerol-free NGS enzymes for use in all steps of a Next Generation Sequencing (“NGS”) workflow.
April 10, 2024
·
3 min read
Press Releases
Meridian Bioscience Wins the CDC’s Lead Detect Prize Competition, Building on Decades of Leadership in Blood Lead Testing at the Point of Care
November 7, 2024
·
4 min read
BioMidwest
Meridian Bioscience Earns EcoVadis Bronze Medal in Recognition of Its Dedication to Sustainability
Meridian Bioscience, Inc. has been awarded the distinguished EcoVadis Bronze Medal in recognition of the commitment to its sustainable business practices.
November 28, 2023
·
2 min read
Press Releases
Meridian Bioscience Leads the Way with Innovative Sustainable Solutions for in vitro Diagnostic Manufacturers
July 24, 2024
·
4 min read
BioMidwest
Meridian Bioscience Senior Director of R&D, Dr. Dan (Dror) Siman-Tov, to Spotlight Lateral Flow Innovations at the Advanced Lateral Flow Conference 2024
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, is proud to announce that Dr. Dan Siman-Tov, Ph.D., MBA, Senior Director of R&D, Diagnostics, will be presenting at the Advanced Lateral Flow Conference 2024.
February 12, 2024
·
3 min read
BioMidwest
Centene Subsidiary Meridian in Michigan Awarded Michigan Medicaid Contracts
Centene Corporation announced that its subsidiary, Meridian in Michigan, has been selected by the Michigan Department of Health and Human Services to continue to serve as a Medicaid health plan for the Comprehensive Health Care Program, which serves nearly 2 million Michiganders statewide.
April 9, 2024
·
10 min read
Pharm Country
SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on health security and infectious disease, announced that it entered into an amendment to its international promotion agreement with Meridian Medical Technologies, Inc.
April 1, 2024
·
7 min read
BioMidwest
Meridian Bioscience Continues Expansion of H. pylori Diagnostic Testing Solutions with FDA Clearance of Premier HpSA Flex
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) has cleared Premier® HpSA® FLEX™ for the diagnosis of H. pylori in both preserved and unpreserved stools.
July 25, 2023
·
3 min read
1 of 3,869
Next
